The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture.
about
Immune selection during tumor checkpoint inhibition therapy paves way for NK-cell "missing self" recognition.Surface marker profiling of SH-SY5Y cells enables small molecule screens identifying BMP4 as a modulator of neuroblastoma differentiationAssociation between PD-L1 expression combined with tumor-infiltrating lymphocytes and the prognosis of patients with advanced hypopharyngeal squamous cell carcinoma.The devil is in the details: Genomics of transmissible cancers in Tasmanian devilsRegulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment
P2860
The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The Escape of Cancer from T Ce ...... and Tumor Tissue Architecture.
@en
The Escape of Cancer from T Ce ...... and Tumor Tissue Architecture.
@nl
type
label
The Escape of Cancer from T Ce ...... and Tumor Tissue Architecture.
@en
The Escape of Cancer from T Ce ...... and Tumor Tissue Architecture.
@nl
prefLabel
The Escape of Cancer from T Ce ...... and Tumor Tissue Architecture.
@en
The Escape of Cancer from T Ce ...... and Tumor Tissue Architecture.
@nl
P2093
P2860
P356
P1433
P1476
The Escape of Cancer from T Ce ...... and Tumor Tissue Architecture.
@en
P2093
Abel Sánchez-Palencia
Federico Garrido
Francisco Perea
Francisco Ruiz-Cabello
Mónica Bernal
P2860
P356
10.3390/VACCINES5010007
P577
2017-02-27T00:00:00Z